Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-10T05:15:15.637Z Has data issue: false hasContentIssue false

Section 4 - Summary and Conclusions

Published online by Cambridge University Press:  05 September 2012

Edited by
Nancy J. Wesensten
Nancy J. Wesensten
Affiliation:
Walter Reed Army Institute of Research, Silver Spring, Maryland
Get access

Summary

Stimulant use has been a feature of some military operations. Caffeine, amphetamines were used by German, British, American, and Japanese forces during WWII, both for their fatigue-ameliorating effects and for their effects on mood and morale. The US Air Force (USAF) officially sanctioned amphetamines to promote alertness in selected aircrew within the Strategic Air Command (SAC) in 1960 and within the Tactical Air Command (TAC) in 1962. The US military maintains a stimulant policy while most of its allies do not allow use of stimulants to maintain/restore performance and manage fatigue. A review of international military service policies reveals a variety of policies on pharmacological fatigue management. Force Health Protection (FHP) is defined specifically as "an organized program of healthcare preventive or therapeutic treatment, or preparations for such treatment, designed to meet the actual, anticipated, or potential needs of a group of military personnel in relation to military missions".
Type
Chapter
Information
Sleep Deprivation, Stimulant Medications, and Cognition , pp. 237 - 267
Publisher: Cambridge University Press
Print publication year: 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Summary and Conclusions
  • Edited by Nancy J. Wesensten
  • Book: Sleep Deprivation, Stimulant Medications, and Cognition
  • Online publication: 05 September 2012
  • Chapter DOI: https://doi.org/10.1017/CBO9780511783005.019
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Summary and Conclusions
  • Edited by Nancy J. Wesensten
  • Book: Sleep Deprivation, Stimulant Medications, and Cognition
  • Online publication: 05 September 2012
  • Chapter DOI: https://doi.org/10.1017/CBO9780511783005.019
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Summary and Conclusions
  • Edited by Nancy J. Wesensten
  • Book: Sleep Deprivation, Stimulant Medications, and Cognition
  • Online publication: 05 September 2012
  • Chapter DOI: https://doi.org/10.1017/CBO9780511783005.019
Available formats
×